Ongrádi, József, Kövesdi, Valéria, Medveczky, G Péter · Orvosi hetilap · 2010 · DOI
Human herpesvirus 6 (HHV-6) is a common virus that most people catch in early childhood, usually causing mild symptoms or no symptoms at all. The virus stays dormant in your body for life but can reactivate, especially if your immune system is weakened. Research suggests HHV-6 may play a role in ME/CFS and other serious conditions, possibly by changing how your immune system produces certain signaling molecules.
This study is important because it identifies HHV-6 as a potential contributing factor in ME/CFS pathogenesis, suggesting that understanding viral reactivation and immune dysregulation could lead to better diagnostic and therapeutic approaches. For ME/CFS patients, this work provides scientific basis for investigating whether antiviral treatments or immune-modulating therapies targeting HHV-6 might be beneficial.
This review does not establish causation—it identifies HHV-6 as a cofactor, meaning the virus may contribute to disease but does not directly cause ME/CFS on its own. The study does not provide direct clinical trial evidence that treating HHV-6 improves ME/CFS outcomes, nor does it clarify the exact mechanisms by which variant A causes disease. Association with a condition does not prove the virus is the primary driver of pathology.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →